Stay updated on Dupilumab in ABPA Treatment Clinical Trial

Sign up to get notified when there's something new on the Dupilumab in ABPA Treatment Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dupilumab in ABPA Treatment Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. No visible changes to the study details or page layout.
    Difference
    0.0%
    Check dated 2026-03-12T21:29:37.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    New revision label 'Revision: v3.4.2' appears, replacing 'Revision: v3.4.1', indicating a minor site update that does not change study details.
    Difference
    0.0%
    Check dated 2026-02-12T01:54:26.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    A minor update shows the page revision label changing from v3.4.0 to v3.4.1 (the addition of Revision: v3.4.1 and removal of Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T23:24:12.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page now shows a 'Show glossary' option and a QC-related 'Last Update Submitted that Met QC Criteria' label, and the footer includes 'No FEAR Act Data' and 'Revision: v3.4.0' replacing earlier text. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T19:59:08.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Minor revision label updated from v3.3.3 to v3.3.4 on the page, with no changes to study content, enrollment, outcomes, or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:54:40.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Locations section expanded to include Alabama, Arizona, California, Idaho, Iowa, New York, Ohio, Pennsylvania, Saxony, North Holland, Bihor County, England, and West Yorkshire; the HHS Vulnerability Disclosure footer link was removed and the revision updated to v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T21:19:47.000Z thumbnail image

Stay in the know with updates to Dupilumab in ABPA Treatment Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dupilumab in ABPA Treatment Clinical Trial page.